Potential pitfalls when interpreting plasma BNP levels in heart failure practice

Sudoh, 1988, A new natriuretic peptide in porcine brain, Nature, 332, 78, 10.1038/332078a0 Tsutsui, 2019, JCS 2017/JHFS 2017 guideline on diagnosis and treatment of acute and chronic heart failure – digest version, Circ J, 83, 2084, 10.1253/circj.CJ-19-0342 Ponikowski, 2016, Eur Heart J, 37, 2129, 10.1093/eurheartj/ehw128 Yancy, 2017, Circulation, 136, e137, 10.1161/CIR.0000000000000509 Nishikimi, 2013, Complexity of molecular forms of B-type natriuretic peptide in heart failure, Heart, 99, 677, 10.1136/heartjnl-2012-302929 Schellenberger, 2006, The precursor to B-type natriuretic peptide is an O-linked glycoprotein, Arch Biochem Biophys, 451, 160, 10.1016/j.abb.2006.03.028 Semenov, 2009, Processing of pro-brain natriuretic peptide is suppressed by O-glycosylation in the region close to the cleavage site, Clin Chem, 55, 489, 10.1373/clinchem.2008.113373 Nishikimi, 2015, Pro-B-type natriuretic peptide is cleaved intracellularly: impact of distance between O-glycosylation and cleavage sites, Am J Physiol Regul Integr Comp Physiol, 309, R639, 10.1152/ajpregu.00074.2015 Nishikimi, 2010, Diversity of molecular forms of plasma brain natriuretic peptide in heart failure–different proBNP-108 to BNP-32 ratios in atrial and ventricular overload, Heart, 96, 432, 10.1136/hrt.2009.178392 Nakagawa, 2017, MiR30-GALNT1/2 axis-mediated glycosylation contributes to the increased secretion of inactive human prohormone for brain natriuretic peptide (proBNP) from failing hearts, J Am Heart Assoc, 6, 10.1161/JAHA.116.003601 Nishikimi, 2007, Do commercially available assay kits for B-type natriuretic peptide measure pro-BNP1-108, as well as BNP1-32?, Hypertension, 50, e163, 10.1161/HYPERTENSIONAHA.107.098350 Nishikimi, 2013, Direct immunochemiluminescent assay for proBNP and total BNP in human plasma proBNP and total BNP levels in normal and heart failure, PLoS One, 8, e53233, 10.1371/journal.pone.0053233 Liang, 2007, Evidence for functional heterogeneity of circulating B-type natriuretic peptide, J Am Coll Cardiol, 49, 1071, 10.1016/j.jacc.2006.10.063 Menon, 2009, Clinical implications of defective B-type natriuretic peptide, Clin Cardiol, 32, E36, 10.1002/clc.20480 Vodovar, 2014, Post-translational modifications enhance NT-proBNP and BNP production in acute decompensated heart failure, Eur Heart J, 35, 3434, 10.1093/eurheartj/ehu314 Takahama, 2018, Ratio of pro-B-type natriuretic peptide (BNP) to total BNP is decreased in mild, but not severe, acute decompensated heart failure patients: a novel compensatory mechanism for acute heart failure, Int J Cardiol, 258, 165, 10.1016/j.ijcard.2017.12.047 Nagase, 1997, Tissue distribution and localization of natriuretic peptide receptor subtypes in stroke-prone spontaneously hypertensive rats, J Hypertens, 15, 1235, 10.1097/00004872-199715110-00007 Schulz, 1988, Neutral metalloendopeptidase (EC 3.4.24.11) in the proximal tubule of the human kidney, Lab Invest, 59, 789 Nishikimi, 2012, The effect of glycosylation on plasma N-terminal proBNP-76 levels in patients with heart or renal failure, Heart, 98, 152, 10.1136/heartjnl-2011-300102 Spanaus, 2007, B-type natriuretic peptide concentrations predict the progression of nondiabetic chronic kidney disease: the Mild-to-Moderate Kidney Disease Study, Clin Chem, 53, 1264, 10.1373/clinchem.2006.083170 Lubien, 2002, Utility of B-natriuretic peptide in detecting diastolic dysfunction: comparison with Doppler velocity recordings, Circulation, 105, 595, 10.1161/hc0502.103010 Scholz, 1988, Age-related changes in normal human hearts during the first 10 decades of life. Part I (growth): a quantitative anatomic study of 200 specimens from subjects from birth to 19 years old, Mayo Clin Proc, 63, 126, 10.1016/S0025-6196(12)64945-3 Ray, 2005, Comparison of brain natriuretic peptide and probrain natriuretic peptide in the diagnosis of cardiogenic pulmonary pulmonary edema in patients aged 65 and older, J Am Geriatr Soc, 53, 643, 10.1111/j.1532-5415.2005.53213.x Seegers, 2015, Natriuretic peptides for the detection of paroxysmal atrial fibrillation, Open Heart, 2, 10.1136/openhrt-2014-000182 Inoue, 2000, Atrium as a source of brain natriuretic polypeptide in patients with atrial fibrillation, J Card Fail, 6, 92, 10.1016/S1071-9164(00)90010-1 Knudsen, 2005, Impact of atrial fibrillation on the diagnostic performance of B-type natriuretic peptide concentration in dyspneic patients: an analysis from the breathing not properly multinational study, J Am Coll Cardiol, 46, 838, 10.1016/j.jacc.2005.05.057 Harada, 1999, Effect of interleukin-1 beta on cardiac hypertrophy and production of natriuretic peptides in rat cardiocyte culture, J Mol Cell Cardiol, 31, 1997, 10.1006/jmcc.1999.1030 Moreels, 2010, Fulminant myocarditis with dramatic response to corticoids, Acta Cardiol, 65, 97, 10.2143/AC.65.1.2045898 Talha, 2011, Mechanisms involved in increased plasma brain natriuretic peptide after heart transplantation, Cardiovasc Res, 89, 273, 10.1093/cvr/cvq331 Bando, 2017, Plasma brain natriuretic peptide levels are elevated in patients with cancer, PLoS One, 12, 10.1371/journal.pone.0178607 Kohno, 1993, Stimulation of brain natriuretic peptide release from the heart by thyroid hormone, Metabolism, 42, 1059, 10.1016/0026-0495(93)90023-H Kato, 2009, Serum concentrations of BNP and ANP in patients with thyrotoxicosis, Endocr J, 56, 17, 10.1507/endocrj.K08E-145 McMurray, 2014, Angiotensin-neprilysin inhibition versus enalapril in heart failure, N Engl J Med, 371, 993, 10.1056/NEJMoa1409077 Ozaki, 1999, Enzymatic inactivation of major circulating forms of atrial and brain natriuretic peptides, Eur J Pharmacol, 370, 307, 10.1016/S0014-2999(99)00115-6 Richards, 1993, Plasma brain natriuretic peptide and endopeptidase 24.11 inhibition inhypertension, Hypertension, 22, 231, 10.1161/01.HYP.22.2.231 Packer, 2015, Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure, Circulation, 131, 54, 10.1161/CIRCULATIONAHA.114.013748 Myhre, 2019, B-type natriuretic peptide during treatment with sacubitril/valsartan: the PARADIGM-HF trial, J Am Coll Cardiol, 73, 1264, 10.1016/j.jacc.2019.01.018 Velazquez, 2019, Angiotensin-neprilysin inhibition in acute decompensated heart failure, N Engl J Med, 380, 539, 10.1056/NEJMoa1812851 Abellas-Sequeiros, 2020, Sacubitril/valsartan and B-type natriuretic peptide value: recalculating route, Eur J Heart Fail, 22, 162, 10.1002/ejhf.1589 Nakagawa, 2018, Macro-pro-B-type natriuretic peptide (proBNP) and hidden macro-N-terminal proBNP: case report, Clin Biochem, 52, 148, 10.1016/j.clinbiochem.2017.10.019 Sakai, 2009, Falsely elevated thyroid-stimulating hormone (TSH) level due to macro-TSH, Endocr J, 56, 435, 10.1507/endocrj.K08E-361 Mehra, 2004, Obesity and suppressed B-type natriuretic peptide levels in heart failure, J Am Coll Cardiol, 43, 1590, 10.1016/j.jacc.2003.10.066 Nishikimi, 2009, Stimulatory and inhibitory regulation of lipolysis by the NPR-A/cGMP/PKG and NPR-C/G(i) pathways in rat cultured adipocytes, Regul Pept, 153, 56, 10.1016/j.regpep.2008.10.010 Wang, 2004, Impact of obesity on plasma natriuretic peptide levels, Circulation, 109, 594, 10.1161/01.CIR.0000112582.16683.EA Mizuno, 2013, Cardiac production of B-type natriuretic peptide is inversely related to the plasma level of free fatty acids in obese individuals – possible involvement of the insulin resistance, Endocr J, 60, 87, 10.1507/endocrj.EJ12-0239 Lewis, 2019, ProBNP that is not glycosylated at threonine 71 is decreased with obesity in patients with heart failure, Clin Chem, 65, 1115, 10.1373/clinchem.2019.302547 Klopfenstein, 1990, Increasing atrial pressure during cardiac tamponade does not elevate plasma levels of the peptide ANP in conscious dogs, J Physiol, 421, 309, 10.1113/jphysiol.1990.sp017946 Minai, 2013, Cardiac tamponade as an independent condition affecting the relationship between the plasma B-type natriuretic peptide levels and cardiac function, Heart Vessels, 28, 510, 10.1007/s00380-012-0278-x Leya, 2005, The efficacy of brain natriuretic peptide levels in differentiating constrictive pericarditis from restrictive cardiomyopathy, J Am Coll Cardiol, 45, 1900, 10.1016/j.jacc.2005.03.050 Omar, 2015, Acute cardiogenic pulmonary edema with normal BNP: the value of repeat BNP testing, Am J Emerg Med, 33, 10.1016/j.ajem.2014.10.006 Weber, 2006, Release pattern of N-terminal pro B-type natriuretic peptide (NT-proBNP) in acute coronary syndromes, Clin Res Cardiol, 95, 270, 10.1007/s00392-006-0375-x Gegenhuber, 2004, Time course of B-type natriuretic peptide and N-terminal proBNP changes in patients with decompensated heart failure, Clin Chem, 50, 454, 10.1373/clinchem.2003.028712 Saenger, 2019, Cardiac troponin and natriuretic peptide analytical interferences from hemolysis and biotin: educational aids from the IFCC Committee on Cardiac Biomarkers (IFCC C-CB), Clin Chem Lab Med, 57, 633, 10.1515/cclm-2018-0905 Tsuji, 2004, E test ‘TOSOH’ II (BNP) nokisotekikentou Iryotokensakiki•, Shinyaku, 27, 31